Top Wall Street analysts upgraded Grupo Cibest, Lufax, Honeywell, and Gossamer Bio. JBS also received an upgrade. See what analysts think.
BofA upgraded Honeywell from Underperform to Neutral with $265 target, confirming analyst confidence in industrial IoT and enterprise automation. The rating shift validates enterprise automation cycles amid digital transformation priorities, though Neutral suggests measured market momentum.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Goldman Sachs analyst Tito Labarta upgraded Grupo Cibest SA ADR (NYSE:CIB) from Neutral to Buy and raised the price target from $81 to $98.
Grupo Cibest shares closed at $87.93 on Monday.
See how other analysts view this stock.
Wall Street analysts change outlook on top names. Check analyst ratings page for all changes. Consider buying HONA stock -…
Analysts change outlook on top Wall Street names, including initiations, upgrades, and downgrades. Check our analyst ratings page…
Top Wall Street analysts change outlook on top names. See all analyst rating changes at…
Analysts upgraded HAL, TKO, RRR, FCEL, and IRT stocks, with raised price targets. Check out other analysts' views and ratings on…
Wall Street analysts changed outlook on top names. For complete changes, see analyst ratings page. AFRM upgraded, LYB raised…
Wall Street analysts change outlook on top names. See all rating changes, upgrades, downgrades and initiations at Benzinga's…
